John B. Ketchum's most recent trade in Tango Therapeutics Inc was a trade of 37,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tango Therapeutics Inc | John B. Ketchum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 37,500 | 37,500 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | John B. Ketchum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 6,250 | 20,937 | - | 0 | Common Stock | |
| Tango Therapeutics Inc | John B. Ketchum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 28,125 | 28,125 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | John B. Ketchum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 4,687 | 14,687 | - | 0 | Common Stock | |
| Tango Therapeutics Inc | John B. Ketchum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Tango Therapeutics Inc | John B. Ketchum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2023 | 10,000 | 10,000 | - | 0 | Common Stock |